Clinical Trial Results TV
September 24, 2010: Dr. Robert A. Byrne and Dr. Michelle O'Donoghue discuss the clinical trial LANCELOT ACS: A Prospective, Randomized, Doub
Dr. Robert A. Byrne and Dr. Michelle O'Donoghue discuss the clinical trial LANCELOT ACS: A
Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of a Reversible PAR-1
Thrombin Receptor Antagonist in Patients with Acute Coronary Syndromes at TCT 2010.

TBA

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
08-22-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted